Evaluation of Patients With Known or Suspected Heart Disease

Evaluation of Patients With Known or Suspected Heart Disease (Screening Protocol)

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00001313

Enrollment

Unknown

Registered

1999-11-04

Start date

1992-05-10

Completion date

2009-01-06

Last updated

2017-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Disease, Diabetes and Heart Failure, Dilated Cardiomyopathy, Heart Failure, Peripheral Artery Disease, Pulmonary Hypertension, Renal Artery Stenosis

Keywords

Cardiac Diagnosis, Chest Pain, Hypertrophic Cardiomyopathy, Coronary Artery Disease, Microvascular Angina, Cardiac Investigation, Follow-up, Heart Disease

Brief summary

In this study researchers will admit and evaluate patients with known or suspected heart disease referred to the Cardiology Branch of the National Heart, Lung, and Blood Institute (NHLBI). Patients participating in this study will undergo a general medical evaluation, including blood tests, urine, examination, chest x-ray and electrocardiogram (EKG). In addition, patients may be asked to have an echocardiogram (ultrasound scan of the heart) and to perform an exercise stress test. These tests are designed to assess the types and causes of patient's heart diseases and to determine if they can participate in other, specific research studies.

Detailed description

The principal mission of the NIH is the conduct of research that elucidates biological mechanisms, pathogenesis, and treatment of disease. Patients with known or suspected cardiovascular diseases are referred to NHLBI cardiologists for consideration of participation in clinical research protocols. However, eligibility for participation is often uncertain from referral information or even after an outpatient evaluation. The purpose of this protocol is to permit inpatient evaluation of patients for whom participation in clinical research protocols is under consideration in order to determine protocol eligibility by means of conventional laboratory and cardiovascular testing.

Interventions

None listed

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* INCLUSION CRITERIA: The following is a representative list of the types of patient presentations and potential diagnoses eligible for this protocol: 1. Coronary artery disease with angina or inducible myocardial ischemia as determined by noninvasive testing. 2. Cardiomyopathies including congestive phenotypes. 3. Peripheral artery disease with intermittent claudication or limb-threatening ischemia. 4. Renovascular disease with uncontrolled hypertension, intermittent pulmonary edema, or evidence of ischemic nephropathy. 5. Upper extremity peripheral artery disease. 6. Diabetes with heart failure. 7. Pulmonary hypertension.

Exclusion criteria

Pregnancy, for those patients who require catheterization-based diagnostics. Inability to provide informed consent.

Countries

United States

Outcome results